This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Infinity Pharmaceuticals Inc (INFI)

NASDAQ: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 188.17M 307.40M 68.11M 175.74M
Receivables 1.19M 647.00K 0.00 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 1.38M 1.99M 0.00 0.00
Total Current Assets 254.70M 344.57M 224.94M 329.75M
Property, Plant & Equipment, Gross 49.15M 39.93M 27.30M 27.45M
Accumulated Depreciation & Depletion 20.91M 20.96M 23.29M 23.37M
Property, Plant & Equipment, Net 28.24M 18.97M 4.01M 4.08M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 5.88M 5.61M 1.76M 1.83M
Total Non-Current Assets 34.12M 24.58M 5.77M 5.91M
Liabilities & Shareholder Equity
Total Assets 288.82M 369.14M 230.71M 335.66M
Accounts Payable 9.63M 12.61M 6.38M 8.60M
Short Term Debt 416.00K 0.00 6.67M 0.00
Other Current Liabilities 261.00K 0.00 0.00 0.00
Total Current Liabilities 70.06M 54.88M 22.21M 18.66M
Long Term Debt 0.00 0.00 6.46M 0.00
Deferred Income Taxes 4.63M 3.38M 0.00 0.00
Other Non-Current Liabilities 95.98M 101.42M 773.00K 6.79M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 120.21M 104.80M 7.23M 6.79M
Total Liabilities 190.26M 159.67M 29.43M 25.45M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 98.56M 209.47M 201.28M 310.20M
Common Par 49.00K 49.00K 48.00K 48.00K
Additional Paid In Capital 694.05M 676.52M 650.87M 633.04M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -595.59M -467.21M -449.80M -323.02M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 45.00K 114.00K 156.00K 134.00K
Total Capitalization 98.56M 209.47M 207.73M 310.20M
Total Equity 98.56M 209.47M 201.28M 310.20M
Total Liabilities & Stock Equity 288.82M 369.14M 230.71M 335.66M
Total Common Shares Outstanding 49.31M 48.88M 48.23M 47.50M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 49.08M 48.56M 47.94M 31.71M
Diluted Weighted Shares Outstanding 49.08M 48.56M 47.94M 31.71M
Number of Employees 164 195 180 154
Number of Part-Time Employees 0 0 0 0
INFI News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

INFI Infinity Pharmaceuticals Inc

Chart of INFI

Analysts Ratings for INFI

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 5 4 4
Moderate Buy 1 1 1 1
Hold 0 0 1 1
Moderate Sell 0 0 0 0
Strong Sell 1 1 0 0
GET INFI ANALYST REPORT

INFI Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs